Ochre Bio
RNA medicines for liver diseases
Oxford, United Kingdom · Founded 2019
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2019
- Website
- ochre-bio.com
- Last Round
- Series AOct 2022
- Rounds
- 2
About
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
Summary
Ochre Bio is a Biotech company based in Oxford, United Kingdom, founded in 2019. Its most recent funding was a Series A round in Oct 2022. Investors include Khosla Ventures, Backed and Lifeforce Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2022
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ochre-bio"><img src="https://indexed.vc/api/badge/company/ochre-bio" alt="Ochre Bio on Indexed.vc" width="260" height="76" /></a>